Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SQT Biomicroneedling, a brand under Hunan Sunshine Bio-Tech Co., Ltd., is a pioneering biotechnology company specializing in the development and application of sponge spicules for dermatological and aesthetic treatments. The company's core technology utilizes siliceous microneedles extracted from freshwater sponges to create millions of micro-channels in the skin, facilitating the delivery of active ingredients and stimulating natural collagen production. Unlike traditional mechanical microneedling, SQT's biomicroneedling is a manual, non-invasive procedure that significantly shortens the skin renewal cycle from 28 days to approximately 7 days. The company offers a range of specialized sets targeting acne, pigmentation, and anti-aging, and has established a global distribution network across more than 60 countries. SQT continues to innovate in the field of bio-extraction and skin repair, positioning itself as a leader in the "liquid microneedling" market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SQT.